Main Article Content
The article deals with one of the most commonly prescribed group of drugs in gastroenterology — a group of enzyme preparations. Data from studies of their efficacy and safety are given. Although high-quality randomized controlled trials supporting the efficacy of enzyme preparations, as well as the benefits of specific enzyme preparations are practically nonexistent, based on clinical experience, they should still be considered as an effective therapeutic agents of the correction of exocrine pancreatic insufficiency and additional method for relief of pancreatic pain.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Bansi D.S., Price A., Russel C. et al. Fibrosing colonopathy in an adult owing to over dose of pancreatic enzyme supplements // Gut. — 2000. — 46. — 283-285.
Borowitz D., Konstan M.W., O’Rourke A., Cohen M., Hendeles L., Murray F.T. Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis // J. Pediatr. Рharmacol. Ther. — 2007. — 12. — 47-52.
Burton F., Alkaade S., Collins D. et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States // Aliment. Pharmacol. Ther. — 2011. — 33. — 149-159.
De-Madaria E., Abad-González A., Aparicio J.R. et al. Spanish Pancreatic Club recommendation on diagnostic and treatment of chronic pancreatitis // Pancreatology. — 2013. — 13. — 18-28.
DiMagno E.P. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency // Best Pract. Res. Clin. Gastroenterol. — 2001. — 15. — 477-86.
Dominguez-Munoz J.E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis // Clin. Gastroenterol. Hepatol. — 2007. — 5. — 484-8.
Dominguez-Munoz J.E., Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efﬁcacy? // JOP. — 2010. — 11. — 158-62.
Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Figueiras A., Vilarino-Insua M. Effect of the administration schedule on the therapeutic efﬁcacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufﬁciency: a randomized, three-way crossover study // Aliment. Pharmacol. Ther. — 2005. — 21. — 993-1000.
Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Vilarino-Insua M. Optimising the therapy of exocrine pancreatic insufﬁciency by the association of a proton pump inhibitor to enteric coated pancreatic extracts // Gut. — 2006. — 55. — 1056-7.
Giuliano S.A., Dehoorne-Smith M.L., Kale-Pradhan P.B. Pancreatic enzyme products // Ann. Pharmaсother. — 2011. — 45. — 658-666.
Federal Register cited (69 82); Docket No. 2003N-0205. Available at: http:// www.fda.gov/OHRMS/DOCKETS/98fr/04-9652.htm (accessed 25 October 2009).
Ferrone M., Raimondo M., Scolapio J.S. Pancreatic enzyme pharmacotherapy // Рharmacotherapy. — 2007. — 27. — 910-920.
Fieker A., Philpott J., Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future // Clin. Exp. Gastroenterol. — 2011. — 4. — 55-73.
FDA. Guidance for Industry Exocrine Pancreatic Insufficiency Drug Products // Services USDoHaH, ed. — Rockville, MD, 2006.
Forsmark C. Management of Chronic Pancreatitis // Gastroenterology. — 2013. — 144. — 1282-1291.
Frulloni L., Falconi M., Gabbrielli A., Gaia E., Graziani R., Pezzilli R. et al. Italian consensus guidelines for chronic pancreatitis // Dig. Liver Dis. — 2010. — 42 (Suppl. 6). — S381-406.
Kadiyala V., Suleiman S., Conwell D. Pancreatic exocrine insufﬁciency // Gastroentero&Endoscopy News. — June 2012. — 1-11.
Kalnins D., Ellis L., Corey M. et al. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis // J. Pediatr. Gastroenterol. Nutr. — 2006. — 42. — 256-61.
Konstan M.W., Stern R.C., Trout J.R. et al. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy // Aliment. Pharmacol. Ther. — 2004. — 20. — 1365-71.
Layer P., Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives // Pancreas. — 2003. — 26. — 1-7.
Ljeb J.G. II & Forsmark C.E. Review article: pain and chronic pancreatitis // Aliment. Pharmacol. Ther. — 2009. — 29. — 706-719.
Safdi M., Bekal P.K., Martin S., Saeed Z.A., Burton F., Toskes P.P. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis // Pancreas. — 2006. — 33. — 156-62.
Santini B., Antonelli M., Battistini A. et al. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis // Dig. Liver Dis. — 2000. — 32. — 406-11.
Shaﬁq N., Rana S., Bhasin D., Pandhi P., Srivastava P., Sehmby S.S. et al. Pancreatic enzymes for chronic pancreatitis // Cochrane Database Syst. Rev. — 2009. — CD006302.
Stallings V.A., Stark L.J., Robinson K.A. et al. Evidence-based practical recomendations for nutritionrelated management of children and adults with cystic fibrosis and pancreatic insufficiency: results of systematic review // J. Am. Diet. Assoc. — 2008. — 108. — 832-839.
Taylor J.R., Gardner T.B., Waljee A.K., DiMagno M.J., Schoenfeld P.S. Systematic review: efﬁcacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufﬁciency // Aliment. Pharmacol. Ther. — 2010. — 31. — 57-72.
Toouli J., Biankin A.V., Oliver M.R. et al. Management of pancreatic exocrine insufficiency: Austral-Asian Pancreatic Club recommendations // Med. J. Austr. — 2010. — 193. — 461-467.
Van Esch A.A., Wilder-Smith O.H., Jansen J.B., van Goor H., Drenth J.P. Pharmacological management of pain in chronic pancreatitis // Dig. Liver Dis. — 2006. — 38. — 518-26.
Vecht J., Symersky T., Lamers C.B., Masclee A.A. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency // J. Clin. Gastroenterol. — 2006. — 40. — 721–5. — PMID: 16940886.
Waljee A.K., Dimagno M.J., Wu B.U., Schoenfeld P.S., Conwell D.L. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis // Aliment. Pharmacol. Ther. — 2009. — 29. —
Whitcomb D.C., Yadav D., Slivka A. et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2) // Pancreatology. — 2008. — 8. — 520-31.
Whitcomb D.C., Lehman G.A., Vasileva G., Malecka-Panas E., Gubergrits N., Shen Y. et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufﬁciency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial // Am. J. Gastroenterol. — 2010. — 105. — 2276-86.
Winstead N.S., Wilcox C.M. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis: a review // Pancreatology. — 2009. — 9. — 344-50.